Uniseed has returned for the latest round raised by Melbourne spinout ENA Respiratory, which is working on a nasal spray to prevent covid-19.

UPMC Enterprises has contributed to a series B round for Sempre Health, which is building a platform to make drugs more affordable for patients.

Alexandria Venture Investments returned to invest in a series C round that lifted the radiopharmaceutical developer's overall funding to $258m.

Kraft Group has once again participated in a funding round for the RNA drug developer, having backed its series A round three years ago.

Sector report: Healthcare

German Media Pool was among the participants in a $44.2m round that will fund the building of the cannabinoid product developer's production and research facility.

Gene therapy startup VectorY has raised more than $37m in an Eli Lilly-backed seed round while AR helmet developer XYZ Reality pulled in over $28m.

Morningside Venture Investments has led a series B round for the fibrotic diseases-focused spinout that advances University of Strasbourg research.

The Alibaba Health-backed medical data technology and services provider has chosen the US for its planned initial public offering.

The cancer and autoimmune disease drug developer completed a Legend Star-backed series D round led by Mirae Asset Financial Group.